Somahlution Inc - Product Pipeline Analysis, 2017 Update

Somahlution Inc - Product Pipeline Analysis, 2017 Update

Apr 2017 GlobalData Medical Equipments31 Pages Price :
$ 750
Summary

Somahlution Inc (Somahlution) is a biotechnology company that offers discovery, development and commercialization of innovative solutions to advance clinical performance. The company provides duragraft product intended for the preservation, storage and flushing of vascular conduits, a pivotal step in cardiac and peripheral bypass surgeries. It offers research and development approach; product pipeline management, clinical trials, initiated trial and education services. Somahlution provides solutions in the areas of ischemia reperfusion injury, organ and tissue transplantation, cardiothoracic and vascular surgery and renal dialysis. The companys products are used in ischemia reperfusion injury, coronary artery bypass surgery, PCI, peripheral vascular bypass surgery and organ transplantation applications. It sells its products through a network of distributors in the US and abroad. Somahlution is headquartered in Jupiter, Florida, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Somahlution Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Somahlution Inc Company Overview 4
Somahlution Inc Company Snapshot 4
Somahlution Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Somahlution Inc Pipeline Analysis Overview 7
Somahlution Inc - Key Facts 7
Somahlution Inc - Major Products and Services 8
Somahlution Inc Pipeline Products by Development Stage 9
Somahlution Inc Ongoing Clinical Trials by Trial Status 11
Somahlution Inc Pipeline Products Overview 13
Duragraft 13
Duragraft Product Overview 13
Duragraft Clinical Trial 14
SOM-Heart 15
SOM-Heart Product Overview 15
SOM-Kidney 16
SOM-Kidney Product Overview 16
SOM-Liver 17
SOM-Liver Product Overview 17
SOM-Lung 18
SOM-Lung Product Overview 18
Somahlution Inc - Key Competitors 19
Somahlution Inc - Key Employees 20
Somahlution Inc - Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Somahlution Inc, Recent Developments 22
Feb 01, 2017: Somahlution Announces Multiple Site Initiation and Patient Enrollment in Spain for European DuraGraft Registry 22
Jan 04, 2017: Somahlution Announces Patient Enrollment In Duragraft CABG European Registry 22
Oct 04, 2016: Somahlution Announces Study Results Showing DuraGraft Vascular Graft Treatment Improves Long-Term Outcomes in Coronary Artery Bypass Grafting Surgery 23
Jan 06, 2016: Somahlution Announces Collaboration with Owens & Minor's Movianto Group To Provide Global Warehousing Services 23
Oct 29, 2015: DuraGraft Makes a Strong Impression at the EACTS Annual Meeting in Amsterdam during Satellite Symposium Featuring Dr. John R. Pepper 24
Sep 09, 2015: Dr. Louis Perrault Presents Design and Progression of Prospective DuraGraft Study During Recent AATS International Coronary Congress 24
Mar 25, 2015: Somahlution Announces New Global Distribution Partnerships For Duragraft Vascular Conduit Solution 24
Sep 22, 2014: Somahlution Announces CE Mark and European Launch of DuraGraft Vascular Conduit Solution 25
Jul 17, 2014: BioLife Solutions Announces Manufacturing Agreement With Somahlution LLC 26
Jul 17, 2014: BioLife Solutions Announces Manufacturing Agreement With Somahlution 26
Appendix 28
Methodology 28
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Somahlution Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Somahlution Inc Pipeline Products by Equipment Type 5
Somahlution Inc Pipeline Products by Indication 6
Somahlution Inc Ongoing Clinical Trials by Trial Status 6
Somahlution Inc, Key Facts 7
Somahlution Inc, Major Products and Services 8
Somahlution Inc Number of Pipeline Products by Development Stage 9
Somahlution Inc Pipeline Products Summary by Development Stage 10
Somahlution Inc Ongoing Clinical Trials by Trial Status 11
Somahlution Inc Ongoing Clinical Trials Summary 12
Duragraft - Product Status 13
Duragraft - Product Description 13
Duragraft - European (EU) Multi-center Registry to Assess Outcomes in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery: Treatment of Vascular Conduits with Duragraft, a Novel Endothelial Damage Inhibitor [VASC] 14
SOM-Heart - Product Status 15
SOM-Heart - Product Description 15
SOM-Kidney - Product Status 16
SOM-Kidney - Product Description 16
SOM-Liver - Product Status 17
SOM-Liver - Product Description 17
SOM-Lung - Product Status 18
SOM-Lung - Product Description 18
Somahlution Inc, Key Employees 20
Glossary 29

List of Figures
Somahlution Inc Pipeline Products by Equipment Type 5
Somahlution Inc Pipeline Products by Development Stage 9
Somahlution Inc Ongoing Clinical Trials by Trial Status 11

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 750
$ 1500

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top